What is trastuzumab emtansine?

Trastuzumab emtansine is an anticancer medication, with the following detailed information:

Trastuzumab emtansine is composed of trastuzumab linked to a small-molecule microtubule inhibitor, DM1. It is used to treat various cancers, including melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, Hodgkin lymphoma, and metastatic gastric cancer. It can also be used as adjuvant therapy for conditions such as metastatic breast cancer, metastatic gastric cancer, and breast cancer, enhancing the body's immune system ability to attack cancer cells. Possible side effects after administration include abdominal pain, vomiting, bleeding, difficulty breathing, and thrombocytopenia.

The medication should be taken correctly under a doctor's guidance. Patients should avoid adjusting the dosage on their own, as this may affect the drug's efficacy.